Hematology Disease
Mostrando 1-12 de 57 artigos, teses e dissertações.
-
1. É necessário encaminhar pacientes com traço falciforme ao hematologista?
Não é necessário encaminhar pacientes com traço falciforme ao hematologista.
Portadores de traço falciforme não possuem uma doença, mas uma característica genética que não requer tratamento.
Esse achado é detectado pela eletroforese de hemoglobina ou pelo Teste do Pezinho que identifica mutação de um alelo do gene da hemoglobina,
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
2. Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature
Abstract Introduction Coronavirus disease 2019 (COVID-19) may present with extrapulmonary manifestations, including hematologic changes. Previous studies suggest that severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) can interact with the renin-angiotensin system, ultimately causing increased production of angiotensin II. By reporting the cases o
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
3. The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome
ABSTRACT Introduction: The myelodysplastic syndrome (MDS) represents a group of hematopoietic neoplasms that is characterized by clonal hematopoiesis, cytopenia and abnormal cellular maturation. Red cell distribution width (RDW) refers to the variation degree of erythrocyte size and it is a reflection of anisocytosis. Higher values have been linked to adver
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
4. Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring
ABSTRACT This manuscript summarizes the results of the consensus meeting composed of hematologists and cardiologists to establish recommendations for the prevention and follow-up of cardiovascular (CV) risk in patients with chronic myeloid leukemia (CML) treated with BCR-ABL tyrosine kinase inhibitors (TKIs) from the point of view of clinical practice and fr
Hematol., Transfus. Cell Ther.. Publicado em: 2021-06
-
5. Epidemiological evaluation and survival of children with acute myeloid leukemia
Abstract Objective: This study aims to describe the epidemiological characteristics and survival rates of children with acute myeloid leukemia treated in hospitals in southern Brazil and compare them with international data. Methods: A multicenter cohort study was conducted with retrospective data collection of all new patients with acute myeloid leukemia
J. Pediatr. (Rio J.). Publicado em: 2021-04
-
6. Desmopressin acetate use in von Willebrand's disease: a survey on current practices in Brazil
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemented a survey targeting medical doctors involved i
Hematol., Transfus. Cell Ther.. Publicado em: 2021-03
-
7. Erratum on "Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation"
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemented a survey targeting medical doctors involved i
Hematol., Transfus. Cell Ther.. Publicado em: 2021-03
-
8. COVID-19 and acute mesenteric ischemia: A review of literature
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemented a survey targeting medical doctors involved i
Hematol., Transfus. Cell Ther.. Publicado em: 2021-03
-
9. Second COVID-19 infection in a patient with multiple myeloma in Brazil - reinfection or reactivation?
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemented a survey targeting medical doctors involved i
Hematol., Transfus. Cell Ther.. Publicado em: 2021-03
-
10. Outcome of SARS-CoV-2 and immune thrombocytopenia in a pediatric patient
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemented a survey targeting medical doctors involved i
Hematol., Transfus. Cell Ther.. Publicado em: 2021-03
-
11. Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
ABSTRACT Hemostatic abnormalities and thrombotic risk associated with coronavirus disease 2019 (COVID-19) are among the most discussed topics in the management of this disease. The aim of this position paper is to provide the opinion of Brazilian experts on the thromboprophylaxis and management of thrombotic events in patients with suspected COVID-19, in the
Hematol., Transfus. Cell Ther.. Publicado em: 2020-10
-
12. Food insecurity and social support in families of children with sickle-cell disease,
Resumo Objetivo: Avaliar as associações entre insegurança alimentar (IA) e apoio social em famílias de crianças com doença falciforme (DF). Métodos: Estudo transversal feito com as famílias de 190 crianças, de cinco a nove anos, atendidas em um hospital de referência em hematologia no Estado do Rio de Janeiro. A IA foi medida com a escala brasile
J. Pediatr. (Rio J.). Publicado em: 01/07/2019